Filing Details
- Accession Number:
- 0001062993-17-005147
- Form Type:
- 13D Filing
- Publication Date:
- 2017-12-04 14:58:53
- Filed By:
- Saba Capital
- Company:
- Clough Global Opportunities Fund (NYSEMKT:GLO)
- Filing Date:
- 2017-12-04
- SEC Url:
- 13D Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Saba Capital Management | 0 | 2,115,226 | 2,115,226 | 6.56% | ||
| Boaz R. Weinstein | 0 | 2,115,226 | 2,115,226 | 6.56% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 9)
Clough Global Opportunities
Fund
(Name of Issuer)
Common Shares, no par value
(Title of
Class of Securities)
18914E106
(CUSIP Number)
Saba Capital Management, L.P.
405 Lexington
Avenue
58th Floor
New York, NY 10174
Attention:
Michael D'Angelo
(212) 542-4635
(Name, Address
and Telephone Number of Person
Authorized to Receive Notices and
Communications)
November 24, 2017
(Date of Event Which
Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [ ]
(Page 1 of 6 Pages)
______________________________
* The remainder of this
cover page shall be filled out for a reporting person's initial filing on this
form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a
prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 18914E106 | SCHEDULE 13D/A | Page 2 of 6 Pages |
| 1 | NAME OF REPORTING PERSON |
| Saba Capital Management, L.P. | |
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
| (a) [ ] | |
| (b) [ ] | |
| 3 | SEC USE ONLY |
| 4 | SOURCE OF FUNDS |
| OO (see Item 3) | |
| 5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |
| [ ] | |
| 6 | CITIZENSHIP OR PLACE OF ORGANIZATION |
| Delaware | |
| 7 | SOLE VOTING POWER | |
| -0- | ||
| NUMBER OF | ||
| SHARES | 8 | SHARED VOTING POWER |
| BENEFICIALLY | 2,115,226 | |
| OWNED BY | ||
| EACH | 9 | SOLE DISPOSITIVE POWER |
| REPORTING | -0- | |
| PERSON WITH: | ||
| 10 | SHARED DISPOSITIVE POWER | |
| 2,115,226 | ||
| 11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON |
| 2,115,226 | |
| 12 | CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
| [ ] | |
| 13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |
| 6.56%1 | |
| 14 | TYPE OF REPORTING PERSON |
| PN; IA | |
___________________________________________________
1
The percentages used herein are calculated based upon 32,224,411 shares of
common stock outstanding as of 11/13/2017, as disclosed in the company's
Certified Shareholder Report Form SC -TO I/A filed 11/13/2017(i.e., total
outstanding shares less the percentage tendered).
| CUSIP No. 18914E106 | SCHEDULE 13D/A | Page 3 of 6 Pages |
| 1 | NAME OF REPORTING PERSON |
| Boaz R. Weinstein | |
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
| (a) [ ] | |
| (b) [ ] | |
| 3 | SEC USE ONLY |
| 4 | SOURCE OF FUNDS |
| OO (see Item 3) | |
| 5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |
| [ ] | |
| 6 | CITIZENSHIP OR PLACE OF ORGANIZATION |
| United States | |
| 7 | SOLE VOTING POWER | |
| -0- | ||
| NUMBER OF | ||
| SHARES | 8 | SHARED VOTING POWER |
| BENEFICIALLY | 2,115,226 | |
| OWNED BY | ||
| EACH | 9 | SOLE DISPOSITIVE POWER |
| REPORTING | -0- | |
| PERSON WITH: | ||
| 10 | SHARED DISPOSITIVE POWER | |
| 2,115,226 | ||
| 11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON |
| 2,115,226 | |
| 12 | CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] |
| [ ] | |
| 13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |
| 6.56%1 | |
| 14 | TYPE OF REPORTING PERSON |
| IN | |
____________________________
1 The percentages used herein are calculated based upon 32,224,411 shares of common stock outstanding as of 11/13/2017, as disclosed in the company's Certified Shareholder Report Form SC- TO I/A filed 11/13/2017 (i.e., total outstanding shares less the percentage tendered) .
| CUSIP No. 18914E106 | SCHEDULE 13D/A | Page 4 of 6 Pages |
| Item 1. | SECURITY AND ISSUER |
| This Amendment No. 9 amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission (the SEC) on 1/6/17, Amendment No. 1 filed on 1/27/17, Amendment No 2 filed on 2/13/17, Amendment No 3 filed on 3/13/17, Amendment No 4 filed on 4/10/17, Amendment No 5 filed on 4/20/17, Amendment No 6 filed on 4/28/17, Amendment No 7 filed on 7/11/17, Amendment No 8 filed on 11/13/17, and Amendment No 9. Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, Amendment No. 8, Amendment No. 9, and the Original Schedule 13D, with respect to the shares of common stock, (the Shares), of Clough Global Opportunities Fund (the Issuer). Capitalized terms used herein and not otherwise defined in this Amendment No. 9 have the meanings set forth in the Original Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, and Amendment No.8. This Amendment No. 9 amends Items 3 and 5 as set forth below. | |
| Item 3. | SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION |
| Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors in SCMF, SCMF II, SCLMF, SCS, SCEF 1, SCEF 2, and Saba Closed-End Funds ETF and the capital appreciation thereon and margin account borrowings made in the ordinary course of business. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein. A total of $7,940,050 was paid to acquire the Common Shares reported herein. | |
| Item 5. | INTEREST IN SECURITIES OF THE ISSUER |
| (a) | See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons. The percentages used in this Schedule 13D/A are calculated based upon 32,224,411 shares of common stock outstanding as of 11/13/2017, as disclosed in the company's Certified Shareholder Report Form SC- TO I/A filed 11/13/2017. |
| (b) | See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. |
| (c) | The transactions in the Shares effected since the filing of the Amendment No 8 by Saba Capital, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference. |
| CUSIP No. 18914E106 | SCHEDULE 13D/A | Page 5 of 6 Pages |
| (d) | No person other than the Reporting Persons and the Saba Entities is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, such Common Shares. |
| (e) | Not applicable. |
SIGNATURES
After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
Date: December 4, 2017
| SABA CAPITAL MANAGEMENT, L.P. | |
| /s/ Michael D'Angelo | |
| Name: Michael D'Angelo | |
| Title: Chief Compliance Officer | |
| BOAZ R. WEINSTEIN | |
| /s/ Michael D'Angelo | |
| Name: Michael D'Angelo | |
| Title: Attorney-in-fact* |
* Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823
| CUSIP No. 18914E106 | SCHEDULE 13D/A | Page 6 of 6 Pages |
Schedule A
This Schedule sets forth information with respect to each purchase and sale of Shares which were effectuated by a Reporting Person since the Schedule 13D/A filing on 11/15/2017. All transactions were effectuated in the open market through a broker.
| Shares | ||
| Trade Date | Purchased (Sold) | Price |
| 12/1/2017 | (76,137) | 10.89 |
| 11/30/2017 | (25,704) | 10.94 |
| 11/28/2017 | (29,093) | 11.15 |
| 11/27/2017 | (20,000) | 11.21 |
| 11/24/2017 | (75,200) | 11.15 |
| 11/22/2017 | (29,653) | 11.07 |
| 11/21/2017 | (39,715) | 11.05 |
| 11/20/2017 | (150,000) | 10.89 |
| 11/17/2017 | (77,235) | 10.85 |
| 11/16/2017 | (77,793) | 10.92 |